MAKINDO MEDICINE · Biochemistry287
Biochemistry I: carbohydrates, ATP, mitochondria and energy metabolism
Core principles: mechanisms are emphasised to explain clinical phenomena, physiological measurements and biochemical disease.
Glycolysis and pyruvate
| Step / enzyme | Substrates and products | Regulation / clinical |
|---|---|---|
| Hexokinase / glucokinase | Glucose → glucose-6-phosphate | Glucokinase in liver/beta cells has higher Km; GCK variants alter glucose sensing |
| Phosphofructokinase-1 | Fructose-6-P → fructose-1,6-bisP | Rate-limiting committed glycolysis; activated AMP/fructose-2,6-bisP, inhibited ATP/citrate |
| Pyruvate kinase | Phosphoenolpyruvate → pyruvate + ATP | Deficiency can cause haemolytic anaemia |
| Lactate dehydrogenase | Pyruvate ↔ lactate with NADH/NAD+ exchange | Regenerates NAD+ in anaerobic glycolysis; lactate not synonymous with tissue hypoxia |
| Pyruvate dehydrogenase | Pyruvate → acetyl-CoA + CO2 + NADH | Requires thiamine, lipoate, CoA, FAD, NAD+; inhibited by acetyl-CoA/NADH |
TCA cycle, respiratory chain and oxidative phosphorylation
- Acetyl-CoA condenses with oxaloacetate via citrate synthase, then proceeds citrate → isocitrate → alpha-ketoglutarate → succinyl-CoA → succinate → fumarate → malate → oxaloacetate.
- Per turn TCA yields 3 NADH, 1 FADH2, 1 GTP and 2 CO2; respiratory chain uses reducing equivalents to pump protons across inner mitochondrial membrane.
- Complex I accepts NADH, complex II succinate-derived FADH2, complex III transfers electrons via cytochrome c, complex IV reduces O2 to water; ATP synthase is complex V.
- Modern approximate ATP yield per glucose in eukaryotic cells is ~30–32 ATP depending on shuttle and tissue (rather than a fixed 36–38).
- Uncouplers dissipate proton gradient producing heat; hypoxia impairs oxidative phosphorylation, contributing to ATP depletion and cellular dysfunction.
Gluconeogenesis and glycogen metabolism
| Pathway | Key steps/enzymes | Clinical consequence |
|---|---|---|
| Gluconeogenesis | Pyruvate carboxylase, PEPCK, fructose-1,6-bisphosphatase, glucose-6-phosphatase | Maintains fasting glucose in liver and kidney |
| Glycogenesis | Glycogen synthase; branching enzyme | Insulin promotes storage |
| Glycogenolysis | Glycogen phosphorylase; debranching enzyme | Glucagon (liver) and adrenaline (muscle/liver) promote mobilisation |
| Pentose phosphate | G6PD generates NADPH and ribose-5-phosphate | G6PD deficiency increases oxidative haemolysis risk |
| Fructose metabolism | Fructokinase/aldolase B | Hereditary fructose intolerance after fructose/sucrose exposure |
| Galactose metabolism | Galactose-1-P uridyltransferase (GALT) | Classic galactosaemia causes neonatal toxicity |
Metabolic regulation across fed and fasting states
- Fed state: high insulin/low glucagon drives glucose uptake into muscle/adipose via GLUT4, glycogen synthesis, glycolysis, lipogenesis and protein synthesis.
- Fasting: liver glycogenolysis is initially important; gluconeogenesis becomes increasingly dominant as hepatic glycogen depletes.
- Prolonged fasting: adipose lipolysis supplies fatty acids and glycerol, liver generates ketones, brain progressively uses ketone bodies, sparing muscle protein.
- Skeletal muscle lacks glucose-6-phosphatase and cannot release free glucose derived from its glycogen; it produces lactate/alanine for hepatic gluconeogenesis.
End of chapter 287